| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.07 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |